Cyclosporin A Inhibits Smooth Muscle Proliferation in the Vascular Response to Injury

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1988 Apr 1

PMID 3258426

Citations 28

Authors

L Jonasson

J Holm

G K Hansson

Affiliations

Soon will be listed here.

Abstract

The arterial response to injury is dominated by proliferation of smooth muscle cells and infiltration of blood-borne cells in the vascular intima. Arterial smooth muscle cell proliferation is under growth factor control, but how this regulation operates in vivo is unclear. We studied the effect on arterial response to mechanical injury of cyclosporin A, a drug that inhibits T-lymphocyte activation. Cyclosporin A treatment at surgery caused a persistent inhibition of the intimal proliferative lesion. Cyclosporin A also inhibited expression of Ia antigens on smooth muscle cells in situ but had no direct effects on smooth muscle cell proliferation in culture. Therefore, the inhibition of intimal cell proliferation appears to be mediated via the immune system.

Citing Articles

Influence of Drug Incorporation on the Physico-Chemical Properties of Poly(l-Lactide) Implant Coating Matrices-A Systematic Study.

Arbeiter D, Reske T, Teske M, Bajer D, Senz V, Schmitz K Polymers (Basel). 2021; 13(2).

PMID: 33477626 PMC: 7831498. DOI: 10.3390/polym13020292.

WD Repeat Domain 1 Deficiency Inhibits Neointima Formation in Mice Carotid Artery by Modulation of Smooth Muscle Cell Migration and Proliferation.

Hu J, Pi S, Xiong M, Liu Z, Huang X, An R Mol Cells. 2020; 43(8):749-762.

PMID: 32868491 PMC: 7468582. DOI: 10.14348/molcells.2020.0085.

The immunology of atherosclerosis.

Gistera A, Hansson G Nat Rev Nephrol. 2017; 13(6):368-380.

PMID: 28392564 DOI: 10.1038/nrneph.2017.51.

Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.

Spitz C, Winkels H, Burger C, Weber C, Lutgens E, Hansson G Cell Mol Life Sci. 2015; 73(5):901-22.

PMID: 26518635 PMC: 11108393. DOI: 10.1007/s00018-015-2080-2.

Anti-inflammatory therapies for atherosclerosis.

Back M, Hansson G Nat Rev Cardiol. 2015; 12(4):199-211.

PMID: 25666404 DOI: 10.1038/nrcardio.2015.5.

References

Ptachcinski R, Burckart G, Venkataramanan R . Cyclosporine. Drug Intell Clin Pharm. 1985; 19(2):90-100. DOI: 10.1177/106002808501900202. View

Thomson A, Whiting P, Simpson J . Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions. 1984; 15(3-4):306-27. DOI: 10.1007/BF01972366. View

Reidy M . A reassessment of endothelial injury and arterial lesion formation. Lab Invest. 1985; 53(5):513-20. View

Autenried P, Halloran P . Cyclosporine blocks the induction of class I and class II MHC products in mouse kidney by graft-vs-host disease. J Immunol. 1985; 135(6):3922-8. View

Shimokado K, Raines E, Madtes D, Barrett T, BENDITT E, Ross R . A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell. 1985; 43(1):277-86. DOI: 10.1016/0092-8674(85)90033-9. View

Ross R . The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986; 314(8):488-500. DOI: 10.1056/NEJM198602203140806. View

Jonasson L, Holm J, Skalli O, Bondjers G, Hansson G . Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986; 6(2):131-8. DOI: 10.1161/01.atv.6.2.131. View

Schwartz S, Campbell G, Campbell J . Replication of smooth muscle cells in vascular disease. Circ Res. 1986; 58(4):427-44. DOI: 10.1161/01.res.58.4.427. View

Kohase M, May L, Vilcek J, Sehgal P . Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell. 1986; 45(5):659-66. DOI: 10.1016/0092-8674(86)90780-4. View

10.

Benveniste E, Merrill J . Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature. 1986; 321(6070):610-3. DOI: 10.1038/321610a0. View

11.

Ross R, Raines E, Bowen-Pope D . The biology of platelet-derived growth factor. Cell. 1986; 46(2):155-69. DOI: 10.1016/0092-8674(86)90733-6. View

12.

Sporn M, Roberts A, Wakefield L, Assoian R . Transforming growth factor-beta: biological function and chemical structure. Science. 1986; 233(4763):532-4. DOI: 10.1126/science.3487831. View

13.

Hansson G, Jonasson L, Holm J, Claesson-Welsh L . Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol. 1986; 64(2):261-8. PMC: 1542359. View

14.

Gauchat J, Khandjian E, Weil R . Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes. Proc Natl Acad Sci U S A. 1986; 83(17):6430-4. PMC: 386517. DOI: 10.1073/pnas.83.17.6430. View

15.

Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G . Cyclosporin-induced endothelial cell injury. Lab Invest. 1986; 55(4):455-62. View

16.

Baumgartner H . [A NEW METHOD FOR THE INDUCTION OF THROMBI BY CONTROLLED OVER-DILATATION OF THE VASCULAR WALL]. Z Gesamte Exp Med. 1963; 137:227-47. View

17.

Weibel E, Staubli W, Gnagi H, Hess F . Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol. 1969; 42(1):68-91. PMC: 2107575. DOI: 10.1083/jcb.42.1.68. View

18.

Borel J, Feurer C, GUBLER H, STAHELIN H . Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976; 6(4):468-75. DOI: 10.1007/BF01973261. View

19.

Clowes A, Karnowsky M . Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 1977; 265(5595):625-6. DOI: 10.1038/265625a0. View

20.

Williams A, Galfre G, Milstein C . Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 1977; 12(3):663-73. DOI: 10.1016/0092-8674(77)90266-5. View